Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CHF 1535 (BDP/Formoterol) DPI vs pMDI in Asthma
NCT00868023Phase 2Completed
- Sponsor
- Chiesi Farmaceutici S.p.A.
- Start
- Feb 2009
- Primary completion
- Jul 2009
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of beclometasone dipropionate + formoterol in asthma, sponsored by Chiesi Farmaceutici S.p.A.. Started Feb 2009; status: completed.
02
Drugs
beclometasone dipropionate + formoterol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00868023.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00868023.